---
layout: post
title: "丽珠医药(01513)拟续聘致同为公司2022年度审计机构"
date: 2022-03-28 18:39:24 +0800
categories: zhitongcaijingwang
tags: 智通财经网新闻
---
<p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/116.01513" data-code="01513|116|5" data-code2="01513|116|3|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=116.01513&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 01513_0" data-code="K 01513|116|5" data-code2="K 01513|116|3|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>丽珠医药(01513)发布公告，公司拟续聘致同会计师事务所(特殊普通合伙)为公司2022年度财务报表及内部控制的审计机构。<br /></p><p class="em_media">（文章来源：智通财经网）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202203282325316020>

[返回智通财经网新闻](//finews.withounder.com/category/zhitongcaijingwang.html)｜[返回首页](//finews.withounder.com/)